Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
- September -
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
- 2009 -
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
September 2009 - 56 products
L
IP
Ecalta 100 mg
Durchstechflasche(n)
395.42
442.80
20 %
Lyophilisate: Anidulafunginum 100 mg
Pfizer AG
● 
A / SL / SO
FB
G
L
IP
CI
Exforge HCT 5 mg/160
mg/12.5 mg
28 Tablet(s)
21.99
39.95
20 %
Coated tablets: 3 Active Agents
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Exforge HCT 5 mg/160
mg/12.5 mg
98 Tablet(s)
76.88
98.65
20 %
Coated tablets: 3 Active Agents
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Exforge HCT 10 mg/160
mg/12.5 mg
28 Tablet(s)
21.99
39.95
20 %
Coated tablets: 3 Active Agents
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Exforge HCT 10 mg/160
mg/12.5 mg
98 Tablet(s)
76.88
98.65
20 %
Coated tablets: 3 Active Agents
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Exforge HCT 5 mg/160
mg/25 mg
28 Tablet(s)
21.99
39.95
20 %
Coated tablets: 3 Active Agents
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Exforge HCT 5 mg/160
mg/25 mg
98 Tablet(s)
76.88
98.65
20 %
Coated tablets: 3 Active Agents
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Exforge HCT 10 mg/160
mg/25 mg
28 Tablet(s)
21.99
39.95
20 %
Coated tablets: 3 Active Agents
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Exforge HCT 10 mg/160
mg/25 mg
98 Tablet(s)
76.88
98.65
20 %
Coated tablets: 3 Active Agents
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
IP
CI
Coveram 5 mg/5 mg
30 Tablet(s)
15.53
33.15
10 %
Tablets: 2 Active Agents
Servier (Suisse) SA
B / SL / SO
FB
G
IP
CI
Coveram 5 mg/5 mg
90 Tablet(s)
40.84
60.45
10 %
Tablets: 2 Active Agents
Servier (Suisse) SA
B / SL / SO
FB
G
IP
CI
Coveram 5 mg/10 mg
30 Tablet(s)
15.53
33.15
10 %
Tablets: 2 Active Agents
Servier (Suisse) SA
B / SL / SO
FB
G
IP
CI
Coveram 10 mg/5 mg
30 Tablet(s)
15.53
33.15
10 %
Tablets: 2 Active Agents
Servier (Suisse) SA
B / SL / SO
FB
G
IP
CI
Coveram 5 mg/10 mg
90 Tablet(s)
40.84
60.45
10 %
Tablets: 2 Active Agents
Servier (Suisse) SA
B / SL / SO
FB
G
IP
CI
Coveram 10 mg/5 mg
90 Tablet(s)
40.84
60.45
10 %
Tablets: 2 Active Agents
Servier (Suisse) SA
B / SL / SO
FB
G
IP
CI
Coveram 10 mg/10 mg
30 Tablet(s)
15.53
33.15
10 %
Tablets: 2 Active Agents
Servier (Suisse) SA
B / SL / SO
FB
G
IP
CI
Coveram 10 mg/10 mg
90 Tablet(s)
40.84
60.45
10 %
Tablets: 2 Active Agents
Servier (Suisse) SA
B / SL / SO
FB
G
IP
CI
Losartan-Mepha 50 mg
28 Tablet(s)
8.05
25.20
10 %
Coated tablets: Losartanum Kalicum 50 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Losartan-Mepha 50 mg
98 Tablet(s)
27.80
46.75
10 %
Coated tablets: Losartanum Kalicum 50 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Losartan-Mepha 100 mg
28 Tablet(s)
11.00
28.40
10 %
Coated tablets: Losartanum Kalicum 100 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Losartan-Mepha 100 mg
98 Tablet(s)
36.90
56.70
10 %
Coated tablets: Losartanum Kalicum 100 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Crilomus 0.5 mg
50 Capsule(s)
57.79
79.25
10 %
Capsules: Tacrolimusum
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Crilomus 0.75 mg
50
71.62
94.30
10 %
Capsules: Tacrolimusum
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Crilomus 1 mg
50 Capsule(s)
85.43
109.35
10 %
Capsules: Tacrolimusum 1 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Crilomus 2 mg
50
161.82
192.40
10 %
Capsules: Tacrolimusum 2 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Crilomus 5 mg
50 Capsule(s)
387.79
438.15
10 %
Capsules: Tacrolimusum 5 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Enalapril-HCT-Mepha
28 Tablet(s)
7.04
16.90
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Enalapril-HCT-Mepha
98 Tablet(s)
24.05
42.60
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
● 
B / SL / SG
FB
G
L
IP
Stamicis
5 Flasche(n)
1547.94
1699.90
10 %
Marker kit: Tetrakis(2-methoxyisobutylisonitril)cupri(i) Tetrafluoroboras 1 mg
b.e.imaging.ag
A / SL / SG
FB
G
L
IP
CI
Multaq, comprimés
pelliculés de 400 mg de
dronédarone
60 Tablet(s)
38.14
57.90
10 %
Dronedaronum 400 mg
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
IP
CI
Multaq, comprimés
pelliculés de 400 mg de
dronédarone
100 Tablet(s)
PR
PR
k.A.
Dronedaronum 400 mg
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
Novaminsulfon Sintetica 500
mg/ml
10 1 ampoule(s) à 2 ml
PR
PR
k.A.
Injection solution: Metamizolum Natricum Monohydricum 500 mg/ml
Sintetica SA
B
FB
G
IP
Novaminsulfon Sintetica 500
mg/ml
10 1 ampoule(s) à 5 ml
PR
PR
k.A.
Injection solution: Metamizolum Natricum Monohydricum 500 mg/ml
Sintetica SA
B
FB
G
IP
CI
A
CM
GEM Bronchialpastillen mit
Codein
24 piece(s)
PR
PR
k.A.
Pastilles: Codeini Phosphas Hemihydricus 3 mg
Tentan AG
B
FB
G
IP
CI
Nicorette Invisi 10 mg/16 h
14 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 15.75 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Invisi 15 mg/ 16 h
14 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 23.62 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Invisi 25 mg/ 16 h
14 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 39.37 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Losartan-Mepha 12.5 mg
7 Tablet(s)
PR
PR
k.A.
Coated tablets: Losartanum Kalicum 12.5 mg
Mepha Pharma AG
B
FB
G
IP
CI
Losartan-Mepha 25 mg
14 Tablet(s)
PR
PR
k.A.
Coated tablets: Losartanum Kalicum 25 mg
Mepha Pharma AG
B
FB
G
IP
CI
Qlaira
28 Dragée(s)
PR
PR
k.A.
Coated tablets: Estradioli Valeras 3 mg
Coated tablets: 2 Active Agents
Coated tablets: 2 Active Agents
Coated tablets: Estradioli Valeras 1 mg
Bayer (Schweiz) AG
B / LPPV
FB
G
IP
CI
Qlaira
3 x 28 Dragée(s)
PR
PR
k.A.
Coated tablets: Estradioli Valeras 3 mg
Coated tablets: 2 Active Agents
Coated tablets: 2 Active Agents
Coated tablets: Estradioli Valeras 1 mg
Bayer (Schweiz) AG
B / LPPV
FB
G
IP
CI
Qlaira
6 x 28 Dragée(s)
PR
PR
k.A.
Coated tablets: Estradioli Valeras 3 mg
Coated tablets: 2 Active Agents
Coated tablets: 2 Active Agents
Coated tablets: Estradioli Valeras 1 mg
Bayer (Schweiz) AG
B / LPPV
FB
G
IP
CI
Yira 20
21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 20
3 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 20
6 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 30
21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 30
3 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 30
6 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
Bupivacain 1mg/mL -
Fentanyl 2 µg/ml
Sintetica
Sachet(s) à 250 ml
PR
PR
k.A.
soluzione per infusione: 2 Active Agents
Sintetica SA
A+
FB
G
IP
Bupivacain 1mg/mL -
Fentanyl 2 µg/ml
Sintetica
5 1 Sachet(s) à 250 ml
PR
PR
k.A.
soluzione per infusione: 2 Active Agents
Sintetica SA
A+
FB
G
IP
Bupivacain 1.25 mg/mL -
Fentanyl 2 µg/ml
Sintetica
Sachet(s) à 250 ml
PR
PR
k.A.
soluzione per infusione: 2 Active Agents
Sintetica SA
A+
FB
G
IP
Bupivacain 1.25 mg/mL -
Fentanyl 2 µg/ml
Sintetica
5 1 Sachet(s) à 250 ml
PR
PR
k.A.
soluzione per infusione: 2 Active Agents
Sintetica SA
A+
FB
G
IP
Irinotecan Orion 40 mg/2 ml
Durchstechflasche(n)
44.51
67.45
k.A.
Orion Pharma AG
A
FB
G
IP
Irinotecan Orion 100 mg/5 ml
Durchstechflasche(n)
107.87
140.25
k.A.
Orion Pharma AG
A
FB
G
IP
Irinotecan Orion 300
mg/15 ml
Durchstechflasche(n)
PR
PR
k.A.
Orion Pharma AG
A
FB
G
IP
Irinotecan Orion 500
mg/25 ml
Durchstechflasche(n)
PR
PR
k.A.
Orion Pharma AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home